Massachusetts General Hospital: Psychotic Disorders trials

The registry lists 16 Psychotic Disorders studies with Massachusetts General Hospital as lead sponsor. 4 are open to participants now and 7 have results posted.

Phase 3 2Phase 4 5No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Changing Lives and Changing Outcomes-9 at Worcester Recovery Center and HospitalRecruitingNCT07359157Not applicable
• A Preventive Behavioral Intervention for Young Adults With Psychotic ExperiencesRecruitingNCT06929442Not applicable
• Development of a Transdiagnostic Intervention for Adolescents at Risk for Serious Mental IllnessRecruitingNCT05962879Not applicable
• Neurobehavioral Mechanisms of Social Isolation and Loneliness in Serious Mental IllnessRecruitingNCT04940663Not applicable
• Effects of Pravastatin on Cholesterol, Inflammation and Cognition in SchizophreniaCompletedNCT01082588Phase 4Results posted
• Seroquel Alone Versus Seroquel With an SSRI for Depression With Psychotic SymptomsTerminatedNCT00955474Phase 4Results posted
• Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated HypertriglyceridemiaCompletedNCT00833976Phase 4Results posted
• A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar DisorderCompletedNCT00621777Phase 4Results posted
• Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With SchizophreniaCompletedNCT00595504Phase 4Results posted
• The Use of Galantamine HBr (Reminyl) in Electroconvulsive Therapy: Impact on Mood and Cognitive FunctioningCompletedNCT00566735Phase 3Results posted
• The Combination of Aripiprazole and Antidepressants in Psychotic Major DepressionCompletedNCT00556140Phase 3Results posted
• Reconnecting to Ourselves and Others in Virtual Meetings (ROOM)Active, not recruitingNCT06360562Not applicable
• Resiliency Training on the College CampusCompletedNCT06038786Not applicable
• Psychosis TMS StudyActive, not recruitingNCT05857137Not applicable
• Risks for Insulin Resistance and Metabolic Syndrome Between Major Depressive Disorder (MDD) or MDD With Psychotic FeaturesTerminatedNCT01310140
• Determining the Safety and Effectiveness of Olanzapine in Children and AdolescentsTerminatedNCT00183612Not applicable